CME Program for Medical Professionals


Thursday, May 22, 2014

Price: $649.00

8 credits


We invite medical professionals to attend this advanced medicine seminar.

AutismOne CME Program for Medical Professionals



Name of Program


AutismOne CME Program for Medical Professionals





Thursday, May 22, 2014





InterContinental Chicago O’Hare Hotel

5300 N. River Road

Rosemont, IL 60018

(847) 544-5300



Overview of Program


This program will provide information for professional medical practitioners concerning the variety of pathophysiological processes frequently encountered in children with autism spectrum disorder.  Topics covered will include metabolic, gastrointestinal, immunological, and neurological dysfunction.  Subtopics that will be covered will include intestinal inflammation, methylation, oxidative stress, immune dysregulation, mitochondrial disorder, and detoxification impairment.  Information will address comorbid disease states present in autism, and which suggest the benefit of a comprehensive approach to treatment.  The program will familiarize practitioners with developing a comprehensive approach in the medical evaluation of ASDs, utilizing the principles of personalized care.



Program Objectives


 The professional will:



Become familiar with the variety of the pathophysiological processes often present in autism spectrum disorder


Understand conditions comorbid with ASD


Be able to more effectively help patients with an ASD with therapies targeting identifiable comorbid pathological processes




8:30 am-10:30 am      Norman Schwartz, MD

10:30 am-11:45 am    Michele Kong, MD

11:45 am-12:00 pm    Q&A with morning presenters

12:00 pm-12:45 pm    break

1:00 pm-3:00 pm        John Hicks, MD

3:00 pm-5:00 pm        Richard Deth, PhD

5:00 pm-5:30 pm        Q&A Panel Discussion                      


How to think about autism for practical purposes of biomedical therapy

Norman Schwartz, MD

We live in a world with so many chronic diseases. With 1 child in 68 now having an autism spectrum disorder, is autism a chronic disease with etiology common to other illnesses? Dr. Norman Schwartz will cover pathways in the body that can be predictive of autism and its comorbid conditions if perturbed by stressors. He will address the topic of epigenetics and what we need to add to our repertoire to bolster the body of parents-to-be and of children to stave off autism as well as what to avoid.

Learning Objectives:

The student will learn:


What the discipline of epigenetics refers to


The metabolic pathways of the body that are most relevant to autism


What can help the metabolic pathways in a susceptible child


What environmental stressors are best to avoid by parents-to-be and children


Norman Schwartz, MD, is an integrative medicine specialist helping individuals and families who are dealing with Down syndrome, autism, ADHD, and other complex chronic medical problems.  Formerly director of integrative medicine for Wheaton Franciscan Healthcare in Wisconsin, he is now in private practice with a special interest in the application of ecological principles to create a safer more sustainable world for present and future generations. 


A Critical Care Approach to the Child with Autism

Michele Kong, MD

This presentation will cover how to medically and critically assess a child with autism in an emergency, including consideration of mitochondrial issues, what anesthesia is safe, what kinds of medication are safe, and how to dose.

Learning objectives:

  1. Early assessment and goal directed therapy in shock
  2. Rapid assessment and management of an acute abdomen
  3. Considerations for acute management of a special needs child


Michele Kong, MD, is a board certified pediatric intensivist who is also the mother of a 6-year old son with autism. She received her MD from the University of Calgary, Canada, and is currently an Assistant Professor of Pediatrics at the University of Alabama at Birmingham. She provides medical care to critically ill children in the Pediatric Intensive Care Unit, with a research focus on understanding host-viral interactions, and development of novel biomarkers and therapeutic targets for respiratory viral infections. She is co-founder of KultureCity, a not-for- profit established to provide direct and tangible assistance to families with special needs children, including scholarships for therapies, respite services, provision of communicative devices and much more.


Treatment of ASD:  Where to begin and how to move forward

John Hicks, MD

As an established physician, the CME Program student is familiar with the systems of the human body. However, how do we define “autism,” and what bearing does this have upon the physician’s perspective toward therapy? What bodily systems and pathologies are primarily involved, and how do we remediate these to enhance health and function and with what order of operations?

John Hicks, MD, will provide a broad survey of systems and symptoms, with emphasis on an insightful patient history, thoughtful assessment, and objective laboratory testing to guide the physician in an individualized treatment plan. Emphasis will also be placed on the use of less aggressive therapies as appropriate in a more sensitive patient population. Questions and discussion will be encouraged.

Learning Objectives:

The student will receive practical information that can be implemented in practice on:

• Taking a history/assessment

• Symptoms and development

• Therapeutic and nutritional diet

• Foundational physiological problems

• Objective laboratory testing for the immune system, GI tract, and more

• Treatments

• Therapies

• Appropriate follow-up

For over thirty five years, Dr. John Hicks has dedicated himself to the art and science of integrated holistic medicine. Using a cooperative medical, nutritional, emotional and energetic approach, Dr. Hicks develops a customized wellness plan for each patient.


Metabolic Roles of Redox Regulation and Methylation: Part I: General Principles

Richard C. Deth, PhD


The ability to resist oxidation and to adapt to environmental stressors is fundamental to homeostasis, and sulfur metabolism provides the foundation for these abilities. Signaling molecules with the ability to change the redox state can exert a broad influence over cellular metabolism, including methylation-mediated epigenetic effects on gene transcription that can persist across the lifespan and even across generations. Conversely, environmental factors which interfere with redox signaling can disrupt its regulatory role, contributing to a number of disorders affecting almost every aspect of physiological function. This lecture will provide an overview of the metabolic and biochemical relationships that control the redox state of cells, including tissue-specific differences.


Metabolic Roles of Redox Regulation and Methylation: Part II: Autism-specific Aspects

Richard C. Deth, PhD


There is extensive evidence indicating the occurrence of oxidative stress, neuroinflammation and impaired methylation in autism and related neurodevelopmental disorders. This knowledge has assisted in identifying treatment approaches which can provide therapeutic benefit for many, but not all individuals. Autism serves to highlight the critical relationship between the GI tract and neurological/immunological development, in which epigenetic regulation plays a key role. The important role of genetic susceptibility can also be viewed within the context of redox and methylation-related metabolism. This lecture will review the scientific evidence for impaired redox and methylation status in autism, including possible causative factors and implications for treatment.


Learning objectives:

The clinician will:

Learn underlying physiological mechanisms vital to a deeper understanding of autism spectrum disorder

Understand the role of methylation in autism spectrum disorder

Understand the role of oxidative stress and inflammation in autism pathology

Understand the interrelationships of different body systems

Understand epigenetic regulation upon body systems



Richard Deth, PhD, is Professor of Pharmacology in the Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University. His recent research has focused on the roles of oxidative stress and impaired methylation in autism, ADHD and other neurological, neuropsychiatric and neurodegenerative disorders.